ACP-103, a 5-HT2A/2C inverse agonist, potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens (Q46748766)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	ACP-103, a 5-HT2A/2C inverse agonist, potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16220333

ACP-103, a 5-HT2A/2C inverse agonist, potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16220333

0 references

pimavanserin tartrate

1 reference

ChEBI release 2020-05-28

nucleus accumbens

1 reference

based on heuristic

inferred from title

author name string

Zhu Li

1

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16220333

Junji Ichikawa

2

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16220333

Mei Huang

3

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16220333

Adam J Prus

4

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16220333

Jin Dai

5

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16220333

Herbert Y Meltzer

6

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16220333

publication date

9 November 2005

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16220333

number of pages

10

1 reference

based on heuristic

inferred from page(s)

Psychopharmacology

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16220333

183

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16220333

2

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16220333

144-153

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16220333

Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects

1 reference

https://api.crossref.org/works/10.1007%2FS00213-005-0170-9

21 January 2018

Relationship between dopaminergic and serotonergic neuronal activity in the frontal cortex and the action of typical and atypical antipsychotic drugs

1 reference

https://api.crossref.org/works/10.1007%2FS00213-005-0170-9

21 January 2018

The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia

1 reference

https://api.crossref.org/works/10.1007%2FS00213-005-0170-9

21 January 2018

SR46349-B, a 5-HT(2A/2C) receptor antagonist, potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens

1 reference

https://pubmed.ncbi.nlm.nih.gov/16220333

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding

1 reference

https://pubmed.ncbi.nlm.nih.gov/16220333

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

SB 242084, a selective serotonin2C receptor antagonist, increases dopaminergic transmission in the mesolimbic system

1 reference

https://pubmed.ncbi.nlm.nih.gov/16220333

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vivo evidence that 5-HT2C receptor antagonist but not agonist modulates cocaine-induced dopamine outflow in the rat nucleus accumbens and striatum.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16220333

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Constitutive activity of the serotonin2C receptor inhibits in vivo dopamine release in the rat striatum and nucleus accumbens.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16220333

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serotonin 5-HT2C agonists selectively inhibit morphine-induced dopamine efflux in the nucleus accumbens

1 reference

https://pubmed.ncbi.nlm.nih.gov/16220333

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Stimulation of 5-hydroxytryptamine (5-HT(2C) ) receptors in the ventrotegmental area inhibits stress-induced but not basal dopamine release in the rat prefrontal cortex

1 reference

https://pubmed.ncbi.nlm.nih.gov/16220333

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

5-HT2A and 5-HT2C/2B receptor subtypes modulate dopamine release induced in vivo by amphetamine and morphine in both the rat nucleus accumbens and striatum.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16220333

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Binding of typical and atypical antipsychotic agents to transiently expressed 5-HT1C receptors

1 reference

https://pubmed.ncbi.nlm.nih.gov/16220333

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serotonin-dopamine interaction in the rat ventral tegmental area: an electrophysiological study in vivo

1 reference

https://pubmed.ncbi.nlm.nih.gov/16220333

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pattern of expression of the serotonin2C receptor messenger RNA in the basal ganglia of adult rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/16220333

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serotonin (5-HT)2C receptors tonically inhibit dopamine (DA) and noradrenaline (NA), but not 5-HT, release in the frontal cortex in vivo

1 reference

https://pubmed.ncbi.nlm.nih.gov/16220333

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acute effects of typical and atypical antipsychotic drugs on the release of dopamine from prefrontal cortex, nucleus accumbens, and striatum of the rat: an in vivo microdialysis study

1 reference

https://pubmed.ncbi.nlm.nih.gov/16220333

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Activation of mesolimbic dopamine function by phencyclidine is enhanced by 5-HT(2C/2B) receptor antagonists: neurochemical and behavioural studies

1 reference

https://pubmed.ncbi.nlm.nih.gov/16220333

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Local infusion of the serotonin antagonists ritanserin or ICS 205,930 increases in vivo dopamine release in the rat medial prefrontal cortex

1 reference

https://pubmed.ncbi.nlm.nih.gov/16220333

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Characterization of typical and atypical antipsychotic drugs based on in vivo occupancy of serotonin2 and dopamine2 receptors

1 reference

https://pubmed.ncbi.nlm.nih.gov/16220333

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Placebo-controlled evaluation of four novel compounds for the treatment of schizophrenia and schizoaffective disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/16220333

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacological characterization of AC-90179 [2-(4-methoxyphenyl)-N-(4-methyl-benzyl)-N-(1-methyl-piperidin-4-yl)-acetamide hydrochloride]: a selective serotonin 2A receptor inverse agonist

1 reference

https://pubmed.ncbi.nlm.nih.gov/16220333

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

5-hydroxytryptamine2A receptor inverse agonists as antipsychotics

1 reference

https://pubmed.ncbi.nlm.nih.gov/16220333

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ritanserin potentiates the stimulatory effects of raclopride on neuronal activity and dopamine release selectivity in the mesolimbic dopaminergic system

1 reference

https://pubmed.ncbi.nlm.nih.gov/16220333

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

5-HT(2A) and D(2) receptor blockade increases cortical DA release via 5-HT(1A) receptor activation: a possible mechanism of atypical antipsychotic-induced cortical dopamine release

1 reference

https://pubmed.ncbi.nlm.nih.gov/16220333

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunohistochemical localisation of the 5-HT2C receptor protein in the rat CNS.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16220333

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Aripiprazole, a novel antipsychotic drug, preferentially increases dopamine release in the prefrontal cortex and hippocampus in rat brain

1 reference

https://pubmed.ncbi.nlm.nih.gov/16220333

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Binding of typical and atypical antipsychotics to 5-HT1C and 5-HT2 sites: clozapine potently interacts with 5-HT1C sites

1 reference

https://pubmed.ncbi.nlm.nih.gov/16220333

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serotonin(2C) receptors tonically suppress the activity of mesocortical dopaminergic and adrenergic, but not serotonergic, pathways: a combined dialysis and electrophysiological analysis in the rat

1 reference

https://pubmed.ncbi.nlm.nih.gov/16220333

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

5-HT(2A) receptor antagonism potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and inhibits that in the nucleus accumbens in a dose-dependent manner

1 reference

https://pubmed.ncbi.nlm.nih.gov/16220333

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The in vivo effects of olanzapine and other antipsychotic agents on receptor occupancy and antagonism of dopamine D1, D2, D3, 5HT2A and muscarinic receptors

1 reference

https://pubmed.ncbi.nlm.nih.gov/16220333

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of antipsychotic drugs on extracellular dopamine levels in rat medial prefrontal cortex and nucleus accumbens

1 reference

https://pubmed.ncbi.nlm.nih.gov/16220333

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inverse agonist activity of atypical antipsychotic drugs at human 5-hydroxytryptamine2C receptors

1 reference

https://pubmed.ncbi.nlm.nih.gov/16220333

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of serotonergic agents on haloperidol-induced striatal dopamine release in vivo: opposite role of 5-HT(2A) and 5-HT(2C) receptor subtypes and significance of the haloperidol dose used

1 reference

https://pubmed.ncbi.nlm.nih.gov/16220333

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Classification of typical and atypical antipsychotic drugs on the basis of dopamine D-1, D-2 and serotonin2 pKi values

1 reference

https://pubmed.ncbi.nlm.nih.gov/16220333

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Distribution of the serotonin 5-HT2 receptor family mRNAs: comparison between 5-HT2A and 5-HT2C receptors

1 reference

https://pubmed.ncbi.nlm.nih.gov/16220333

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Selective blockade of serotonin-2C/2B receptors enhances mesolimbic and mesostriatal dopaminergic function: a combined in vivo electrophysiological and microdialysis study

1 reference

https://pubmed.ncbi.nlm.nih.gov/16220333

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

SB 242084, a selective and brain penetrant 5-HT2C receptor antagonist

1 reference

https://pubmed.ncbi.nlm.nih.gov/16220333

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Localization of the 5-hydroxytryptamine2C receptor protein in human and rat brain using specific antisera.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16220333

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00213-005-0170-9

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16220333

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/16220333

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46748766&oldid=2208068341"